a. Executive Committee. The executive committee shall consist of officers of the Board of Directors. The Executive Committee shall conduct the annual evaluation of the President and other activities as determined by the President and approved by the Board of Directors. The Executive Committee shall report all activity that transpires between scheduled Board meetings to the full Board at the next meeting of the Board.
b. Bylaws Committee. The Bylaws Committee will review these Bylaws and propose changes as they become necessary for action by the Board of Directors.
c. Finance Committee. The Finance Committee shall in conjunction with the President develop and recommend to the Board of Directors an annual budget prior to the beginning of the fiscal year. The Finance Committee will also be responsible for receiving, reviewing and accepting the report on audit, and for its presentation to the Board for final approval. By virtue of his position on the board, the Treasurer will be a member of this committee.
d. International Committee. This committee’s purpose is to keep current with international development, research, and clinical practices in medication assisted treatment. The committee will monitor information from both developed and emerging countries as regards their response to the needs of their citizens who are candidates for medication assisted treatment. The committee will maintain viable communication with recognized international leaders in the field of medication-assisted treatment.
e. Medication Committee. The purpose of the committee is to review the latest information and research on the effectiveness of new medications and pharmaceuticals in order to report on their usefulness in enhancing the quality of care for persons in need of medication assisted treatment and to review external policies that have an impact on service delivery, integrity, quality of care, etc.
f. Membership Committee. This committee will review applications from state associations and other applicants that are interested in becoming a Member of the Association. The Committee will interview the applicants to insure they satisfy requirements. Additionally, the Committee will review member-at-large nominations submitted by the President. The Membership Committee will present their recommendation(s) to the full Board of Directors for final approval. The Committee may, from time to time, review and revise the membership application questionnaire provided to prospective members.
g. Nominating Committee. The Nominating Committee shall solicit nominations from the Board of Directors for the officer positions of the corporation. The Nominating Committee shall recommend to the Board of Directors a slate of nominees for officers to be voted on at the annual Board meeting.
h. Policy Committee – The Policy Committee is responsible for development of advisories and policy statements issued to the field on behalf of the AATOD Board of Directors. The committee will review literature, regulations and pertinent governmental guidelines in preparation of draft policies and present recommendations for review and approval to the AATOD Board of Directors before release of any such document.
i. Risk Management Committee. The purpose of this Committee is to support AATOD’s mission of enhancing the quality of patient care in treatment programs by identifying and monitoring emerging clinical, legal and regulatory issues that are of most of concern in medication assisted treatment, so as to reduce risk and increase patient safety. The committee functions to enhance vigilance of pertinent clinical and legal trends, and to promote awareness of best risk management practices through training and dissemination of information that will be of benefit to patients and programs.
j. Other Committees. The President, with the approval of the Board, may create ad hoc committees as needed. The Board of Directors will specify the duties and end date of such committees.